Cargando…

Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial

INTRODUCTION: As of November 2021, COVID-19 has killed more than 5 million people globally, including over 750 000 in the USA. Apart from corticosteroids, most available therapeutic options are at best marginally efficient in reducing disease severity and are extremely expensive. The systematic inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovre, Dragana, Bateman, Kristin, Sherman, Mya, Fonseca, Vivian A, Lefante, John, Mauvais-Jarvis, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635865/ https://www.ncbi.nlm.nih.gov/pubmed/34848523 http://dx.doi.org/10.1136/bmjopen-2021-053684

Ejemplares similares

Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020)

MON-160 Effect Of The Combination Conjugated Estrogens And Bazedoxifene On Glucose Homeostasis In Obese Postmenopausal Women: A Placebo-controlled Randomized Pilot Trial
por: Lovre, Dragana, et al.
Publicado: (2019)

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial
por: Kralj-Hans, Ines, et al.
Publicado: (2023)

Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
por: Brodin, Daniel, et al.
Publicado: (2023)

Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
por: Shah, Tayyab, et al.
Publicado: (2023)

Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults
por: Ader, Florence
Publicado: (2020)

Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised children
por: Schober, Tilmann, et al.
Publicado: (2022)

Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry
por: Khedar, Raghubir Singh, et al.
Publicado: (2022)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period
por: Sellarès-Nadal, Júlia, et al.
Publicado: (2022)

Impact of isolation on hospitalised patients who are infectious: systematic review with meta-analysis
por: Purssell, Edward, et al.
Publicado: (2020)

Impact of comorbidities on hospitalised Syrian patients with COVID-19: a retrospective study
por: Najjar, Michel, et al.
Publicado: (2023)

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)

ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19
por: McCafferty, Kieran, et al.
Publicado: (2021)

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
por: Mauvais-Jarvis, Franck
Publicado: (2017)

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial
por: León López, Rafael, et al.
Publicado: (2020)

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
por: Inciarte, Alexy, et al.
Publicado: (2021)

Influenza-associated hospitalisation, vaccine uptake and socioeconomic deprivation in an English city region: an ecological study
por: Hungerford, Daniel, et al.
Publicado: (2018)

3219 hospitalised patients with COVID-19 in Southeast Michigan: a retrospective case cohort study
por: Mulhem, Elie, et al.
Publicado: (2021)

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
por: Collard, Didier, et al.
Publicado: (2021)

Ethnicity and outcomes in patients hospitalised with COVID-19 infection in East London: an observational cohort study
por: Apea, Vanessa J, et al.
Publicado: (2021)

Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort study
por: Ombajo, Loice Achieng, et al.
Publicado: (2022)

Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study
por: Lokida, Dewi, et al.
Publicado: (2022)

Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City
por: Paranjpe, Ishan, et al.
Publicado: (2020)

Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA
por: Incerti, Devin, et al.
Publicado: (2021)

Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study
por: Cueto-Manzano, Alfonso M, et al.
Publicado: (2021)

Persistent symptoms and conditions among children and adolescents hospitalised with COVID-19 illness: a qualitative study
por: Messiah, Sarah E, et al.
Publicado: (2023)

Let’s Talk About Antibiotics: a randomised trial of two interventions to reduce antibiotic misuse
por: Goggin, Kathy, et al.
Publicado: (2022)

Modelling study to estimate the health burden of foodborne diseases: cases, general practice consultations and hospitalisations in the UK, 2009
por: O'Brien, Sarah J, et al.
Publicado: (2016)

Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
por: Chen, Liang, et al.
Publicado: (2018)

Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study
por: Reid, Julie C, et al.
Publicado: (2021)

Prognostic associations of ECG tracings in hospitalised patients with COVID-19: a systematic review and meta-analysis protocol
por: Interior, Jasmine S, et al.
Publicado: (2022)

Criteria to achieve safe antimicrobial intravenous-to-oral switch in hospitalised adult populations: a systematic rapid review
por: Harvey, Eleanor J, et al.
Publicado: (2023)

Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data
por: Yokomichi, Hiroshi, et al.
Publicado: (2019)

Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study
por: Hellgren, Lovisa, et al.
Publicado: (2021)

Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
por: Haroon, Shamil, et al.
Publicado: (2022)

Reducing catheter-associated urinary tract infections in hospitals: study protocol for a multi-site randomised controlled study
por: Mitchell, Brett G, et al.
Publicado: (2017)

BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)
por: Pittet, Laure F, et al.
Publicado: (2021)

Deimplementation strategy to reduce overtreatment of asymptomatic bacteriuria: a study protocol for a stepped-wedge cluster randomised trial
por: van Horrik, Tessa MZXK, et al.
Publicado: (2021)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d5984fggaunpkmv5diasnfdg0f